baber/WOPTO huggingface dataset:
Patent CA-2726381-A1 (CA)
Title: Support assembly for a drive mechanism for the installation of geothermal conduits adjacent a foundation wall inside or outside a building structure
Inventor: DESMEULES ALAIN
IPC: E21B15/04
Filed: 2010-12-23
Abstract: A support assembly for a drive mechanism to drive a force transmitting shaft having a soil penetrating head with a geothermal conduit loop attached thereto into the ground under a basement concrete floor, through a hole formed in the concrete floor. The support assembly may also be secured to opposed transverse foundation walls adjacent the building structure and outside the structure. The support assembly includes a support platform formed of platform sections having interconnected flanges. Attachment flanges are also provided at opposed ends of the support platform for detachable securement to opposed transverse foundation walls whereby the support assembly extends diagonally between the opposed transverse walls when mounted internally.                    When secured to the outside of the opposed transverse foundation walls, one of the beam sections extends outwardly from the opposed transverse foundation walls to support the drive mechanism spaced from the foundation walls.
Patent CA-2727175-A1 (CA)
Inventor: CISSE JEAN-CHRISTOPHE
IPC: G06F17/30
Filed: 2011-01-10
Abstract: The specification and drawings present a new method, apparatus and software related product (e.g., computer readable medium) presented for: reading all multi--application files stored in network devices (i.e., in servers, workstations, archives, backup repositories, etc.) comprised in a computer network or reading selected multi-application files comprising one or more predefined features and stored in said network devices using a generic application programming interface (GAPI), followed by creating and/or updating (e.g., periodically) meta-data for the files read by using the GAPI, and/or followed by retrieving requested files out of the multi-application files using the meta-data for the requested files (if the meta-data is created and properly updated).
Patent CA-2727343-A1 (CA)
Inventor: RAYE VICTOR J
IPC: F15B21/00
Filed: 2011-01-11
Abstract: A manifold system and method for installing and/or attaching a manifold system to a trailer/dolly system module. The manifold system includes groove and at least one fastener for securing the manifold system to the system module, allowing for the manifold system to be easily installed and quickly replaceable, which allows for continued use of a trailer/dolly vehicle, while minimizing trailer/dolly down time as well as diagnostic troubleshooting/repair time.
Patent CA-2727688-A1 (CA)
Inventor: LANDA BENZION
IPC: B41F17/00
Filed: 2009-06-16
Abstract: A method for preparing a lenticular guide roll for use in a lenticular printing run. The method comprises providing a printing roll of a printing press and a first piece of lenticular media. The first piece of lenticular printing substrate has a pitch which is substantially identical to a second lenticular printing substrate to be used in the lenticular printing run.  The,method further comprises attaching the first piece of lenticular printing substrate to the printing roll to allow the maneuvering of the second lenticular printing substrate by the printing roll in the printing press.
Patent CA-2729404-A1 (CA)
Title: Microneedle device and method for enhancing the efficacy of influenza vaccine using microneedle device
Inventor: NOZAKI CHIKATERU
IPC: A61L31/00
Filed: 2009-05-22
Abstract: The present invention provides a method for enhancing the immunogenicity using a microneedle device capable of enhancing the immunogenicity of an influenza vaccine. According to the method for enhancing the immunogenicity using the present microneedle device, a microneedle device having microneedles made of polylactic acid, coated with an influenza vaccine composed of an antigen having type A strain (H1N1), type A strain (H3N2), and type B strain as active ingredients is brought into direct contact with the skin so as to transcutaneously administer the aforementioned influenza vaccine. After the transcutaneous administration, lauryl alcohol is applied to the site of the skin where the microneedle device has been brought into direct contact.
Patent CA-2729461-A1 (CA)
Inventor: SOTO-MENDEZ CARLOS
IPC: A44C13/00
Filed: 2011-02-01
Abstract: The invention provides a jewellery product comprising a plurality of filling items trapped in an open-mesh shell. The shell comprises a plurality of mesh openings through which the filling items are unable to pass, and at least one filling opening through which the filling items are able to pass. The filling opening is occluded by an occluding member to trap the filling items within the shell. The invention further provides a method of making the jewellery product.
Patent CA-2729814-A1 (CA)
Title: Procede de preparation de compositions a base de composant amylace et de polymere synthetique
Inventor: FERON THIERRY
IPC: C08L3/02
Filed: 2009-07-17
Abstract: La présente invention a pour objet un procédé de préparation d'une composition à base de polymère synthétique comprenant : l'introduction, dans un réacteur contenant un polymère synthétique (composant 1) ramolli ou fondu, d'un composant amylacé non plastifié (composant 2) et d'un agent plastifiant de celui-ci (composant 3); et le malaxage du mélange obtenu dans des conditions suffisantes pour obtenir la plastification du composant amylacé (composant 2) par l'agent plastifiant (composant 3) et un mélange homogène du polymère synthétique et du composant amylacé plastifié. Le réacteur peut notamment être une extrudeuse, à simple vis ou double vis, à co-rotation ou contre- rotation, par exemple une extrudeuse à double vis et à co-rotation. Le polymère synthétique peut avantageusement être choisi dans le groupe comprenant les polyéthylènes (PE) et polypropylènes (PP), fonctionnalisés et non fonctionnalisés, les polyamides (PA), les polyuréthanes thermoplastiques (TPU), les copolymères styrène-éthylène-butylène-styrène (SEBS), de préférence fonctionnalisés, les poly (téréphtalate d'éthylène) amorphes (PETG) et les mélanges de ceux-ci. Les compositions résultantes présentent des caractéristiques améliorées, notamment en termes de coloration et de propriétés mécaniques, par exemple en termes d'allongement à la rupture.
Patent CA-2731197-A1 (CA)
Title: Method for inhibiting corrosion
Inventor: MACKENZIE CAMERON
IPC: G01N21/64
Filed: 2009-07-20
Abstract: The invention relates to a method for inhibiting corrosion comprising the steps of providing a fluid; adding a cor-rosion inhibitor comprising at least one amphiphilic chemical to the fluid; and monitoring micelles presence in the fluid. A  method for determining the amount of corrosion inhibitor that is sufficient to inhibit corrosion, a method for monitoring the activi-ty of an amphiphilic chemical and a system for inhibiting corrosion in a conduit are also claimed.
Patent CA-2735236-A1 (CA)
Inventor: STALCUP GREGORY C
IPC: A61B17/58
Filed: 2009-08-28
Abstract: An orthopaedic implant system includes an orthopaedic implant implantable at a selected location within a corporeal body. The implant includes a first structural material and a second structural material.      The first structural material is non-resorbable relative to the corporeal body and is different relative to the second structural material. The implant is an internal fixation device.
Patent CA-2735344-A1 (CA)
Inventor: VERMA LILY
IPC: A61K9/107
Filed: 2010-03-04
Abstract: A novel formulation for treating fungal infections comprising Cholesterol containing Nanosomal Amphotericin B in a Saline Suspension
Patent CA-2735548-A1 (CA)
Inventor: STIEF CHRISTIAN
IPC: A46B3/00
Filed: 2009-09-01
Abstract: The present invention is directed to a toothbrush having a handle portion, a neck portion and a head (1), said head (1) being provided with bristle tufts (6) arranged in a complex internal geometry by means of the stapling technique. To enable a visually flawless molding to be produced, material cross-sections in the head (1), in particular in the area of the blind-end holes (11, 12) provided for tufting, are taken into consideration.
Patent CA-2743127-A1 (CA)
Inventor: HASSON ROBERT
IPC: G06F17/30
Filed: 2011-06-13
Abstract: The invention concerns a method of distributing one or more digital vouchers to the communications device of a user comprising: identifying, based on a user input to the communications device (106), a plurality of digital vouchers; displaying on a display of said communications device an advertising link to each of said plurality of digital vouchers; and in response to a selection by said user of one or more of said advertising links, transmitting one or more digital vouchers corresponding to said selected links to said communications device.
Patent CA-2743733-A1 (CA)
Inventor: ROOSE PETER
IPC: C07C233/11
Filed: 2009-11-17
Abstract: The present invention relates to a process for preparing secondary amides with good selectivity by carbonylating a corresponding tertiary amine with carbon monoxide in a reaction mixture in the presence of a metal catalyst and in the presence of a halogen containing promoter. The metal catalyst comprises palladium. A same or even a much better catalytic activity can be obtained with palladium than with the much more expensive rhodium, especially when the palladium is used in a low concentration.  Moreover, also a good selectivity can be achieved.
Patent CA-2743782-A1 (CA)
Title: Therapeutic agent for chorioretinal degenerative disease containing pyridine-3-carbaldehyde o-(piperidin-1-yl-propyl)-oxime derivative as active ingredient
Inventor: HIRAI SHIN-ICHIRO
IPC: A61K31/4545
Filed: 2009-11-18
Abstract: Provided is a novel prophylactic or therapeutic agent for a chorioretinal degenerative disease. The compound of formula (1) or its salt has inhibitory effects on photoreceptor cell death or visual cell death in a mouse model of light damage. Therefore, the compound or its salt is useful as a prophylactic or therapeutic agent for a chorioretinal degenerative disease such as age--related macular degeneration, retinitis pigmentosa. In the formula(1), A is a group (p1), (p2) or (p3); R1 is H, alkyl, aralkyl or OH or its ester; R2 is H or alkyl; R3 is halogen, H, alkyl or OH or its ester; R4 is halogen, H, OH, alkoxy, amino, alkylamino or cycloalkylamino, R3 and R4 may be joined to each other through N to form an unsaturated [1,2,4]oxadiazine ring; R5 is H, alkyl or cycloalkyl; m is 0 or 1; and n is 0 or 1.
Patent CA-2745168-A1 (CA)
Inventor: BRUNELLE HENRY
IPC: A47K3/02
Filed: 2011-06-30
Abstract: A comfort bathtub has at least one heated wall portion which is comprised by a composite plyable heat generating envelope integrated with the wall portion. The heat generating envelope has a heated mesh sandwiched between a pair of protection film sheets bonded together about the heated mesh to isolate the heated mesh from molded material of the bathtub. The composite plyable envelope has electrical connections secured to a power supply. A temperature sensor is in communication with the envelope for sensing the temperature thereof. A voltage regulator controls the power supply through a controller circuit to regulate the heat generated by the heated mesh. The composite plyable envelope is configured to heat a discrete wall portion of the bathtub to provide a discrete external heated surface of the bathtub.
Patent CA-2745371-A1 (CA)
Inventor: CHAHINE MOHAMED
IPC: G01N33/567
Filed: 2009-12-21
Abstract: Reagents, methods and kits for screening for compounds that modulate the activity of voltage-gated sodium channels (NaV), such as human NaV1.5/SCN5A/hH1 are described. The reagents, methods and kits are based on mutated NaV  alpha subunit polyptides of SEQ ID NO:5 with mutations at positions 372, 898, 1419 and 1711 (the DEKA motif) and at positions 11485, 1486 and 1487 (the IFM motif) resulting in increased permeability for a group IIA divalent cation (Ca++) and decreased inactivation rate. The mutant polypeptide is used in a method and kit for determining whether a test compound modulates the channel activity, preferably using a chimeric polypeptide (chameleon polypeptide) comprising calmodulin, a calmodulin binding protein (M13), and two fluorescent agents.
Patent CA-2747849-A1 (CA)
Inventor: KIM JU TAE
IPC: E04F15/024
Filed: 2009-09-09
Abstract: Provided is a floor construction apparatus that includes a guide unit that is disposed on surface of a floor to be constructed, and a flattening unit that is guided by the guide unit, to then be transferred to flatten the surface of the floor to be constructed, and to thereby reduce a construction time and expense for flattening of the construction surface of the floor.
Patent CA-2748007-A1 (CA)
Title: Methods for reducing discomfort during electrostimulation, and compositions and apparatus therefor
Inventor: BIKSON MAROM
IPC: A61N1/04
Filed: 2009-12-30
Abstract: An electrode assembly for neuro-cranial stimulation includes an electrode, a conductive gel, and an adapter including an interior compartment for positioning the electrode relative to the adapter and for receiving and retaining the conductive gel. The conductive gel contacts the electrode along an electrode-gel interface. An orifice at one end of the interior compartment and adjacent to a positioning surface of the adapter for positioning the electrode assembly against a skin surface of a user enables the conductive gel is able to contact the skin surface of the user to define a gel-skin interface, such that a minimum distance between the electrode-gel interface and the gel-skin interface is maintained between 0,25 cm and 1.3 cm. An electrode assembly mounting apparatus is provided for adjustably positioning a plurality of electrode assemblies against target positions on the cranium.
Patent CA-2752199-A1 (CA)
Title: Derives de 3-benzofuranyl-indol-2-one substitues en position 3, leur preparation et leur application en therapeutique
Inventor: BARONI MARCO
IPC: A61P3/00
Filed: 2010-02-09
Abstract: La présente invention a pour objet des dérivés de 3-benzofuranyl-indol-2-one substitués en 3, de formule (I) dans laquelle R1, R2, R3, R4, R5 et n sont tels que définis dans la revendication 1, le procédé de préparation et l'application thérapeutique desdits composés.
Patent CA-2754702-A1 (CA)
Inventor: TAKE YUKINORI
IPC: A61K31/192
Filed: 2010-04-22
Abstract: This invention provides a medicament for the treatment of cancer, which cause a reduction of cancer. This invention relates to use of a compound which has inhibitory activities against prostaglandin E2 receptor (EP4 receptor) and is represented by the following general formula (I), (II), (III), or (IV), or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt for the manufacture of a medicament for the treatment of cancer. The invention relates to a method for treatment of cancer comprising administering the compound or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt to humans or animals. The compound or a pharmaceutically acceptable salt thereof, or the pharmaceutical composition may be used in combination with one or more second active agents.   (see formula I) (see formula II) (see formula III) (see formula IV)
Patent CA-2755084-A1 (CA)
Inventor: DRISCOLL DAVID F
IPC: A61K9/08
Filed: 2010-03-11
Abstract: An emulsion is provided including: an oil component and a water component, the oil component including: fish oil triglycerides in an amount of about 60% to about 90% based on the weight of the oil component; wherein the fish oil triglycerides include omega-3 fatty acids, expressed as triglycerides, in an amount of at least 60%, based on the total weight of the fatty acids of the fish oil triglycerides; wherein the fish oil triglycerides include a total amount of EPA and DHA, expressed as triglycerides, of at least 45%, based on the total weight of the fatty acids of the fish oil triglycerides; and, at least one medium-chain triglyceride, wherein a total amount of the at least one medium-chain triglyceride is from about 10% to about 40% based on the weight of the oil component.
Patent CA-2756853-A1 (CA)
Title: Drug fusions and conjugates
Inventor: HERRING CHRISTOPHER
IPC: A61P3/10
Filed: 2010-03-24
Abstract: The present invention relates to drug fusions that have improved serum half lives. These fusions and conjugates comprise polypeptides, immunoglobulin (antibody) single variable domains and GLP and/or exendin molecules. The invention further relates to uses, formulations, compositions and devices comprising such drug fusions and conjugates.
Patent CA-2759613-A1 (CA)
Inventor: NIRANJAN KARTHIGESU
IPC: H04W4/02
Filed: 2011-11-22
Abstract: A method and a system for point-of-interest search is disclosed. A search request including a location information acquired by a mobile device at a location defined by the location information is received at a server. A search query is formulated using the search request and the location information. The search query is sent to a plurality of search engines and search results are received from the plurality of search engines and aggregated based on the search context.
Patent CA-2760089-A1 (CA)
Inventor: RAPOPORT URI
IPC: A61B5/05
Filed: 2010-04-21
Abstract: The present invention discloses an imaging device within an MRI. In a magnetic resonance imaging system, a spatially fixed coupled imaging device (SFCID) for producing combined anatomical and real time functional light images, the SFCID  functionally incorporates a maneuverable imaging system MIS with a coupled imaging system CIS.
Patent CA-2763265-A1 (CA)
Inventor: HULLIGER URS
IPC: A61B17/80
Filed: 2010-04-20
Abstract: A bone fixation ele-ment comprises a shaft extending longitudinally from a proximal end to a distal end and a head connected to the proximal end of the shaft. The head includes a radially outer abut-ting structure deformable to locking-ly engage an inner wall of an opening through a bone plate. Deformation of the abutting structure permits the head to lock the bone fixation ele-ment within the opening at any user--selected angle with respect to a cen-tral axis of the opening within a per-mitted range of angulation.
Patent CA-2763452-A1 (CA)
Inventor: NILSSON TOMMY
IPC: B65B41/18
Filed: 2010-04-23
Abstract: A packaging material comprising a plurality of magnetisable portions thereon comprising at least one spot per package to be formed from the packaging material is disclosed. At least one of the magnetisable portions, per package, provides a first magnetic mark carrying a magnetic field pattern, and another of the magnetisable portions, per package, provides a second magnetic mark carrying a magnetic field pattern.
Patent CA-2763899-A1 (CA)
Inventor: STOESZ CARL W
IPC: G01B11/16
Filed: 2010-06-03
Abstract: A transducer including a housing; one or more pressure communicating configurations disposed within the housing; one or more selected pressure chambers in operable communication with the one or more pressure communicating configurations; an environmental chamber in operable communication with one or more of the one or more pressure communicating configurations; and a strain member secured to one or more of the one or more pressure communicating configurations and method.
Patent CA-2764449-A1 (CA)
Inventor: LAYZER JULIANNA M
IPC: A61P9/10
Filed: 2010-06-03
Abstract: The present invention relates, in general, to a pharmacologic system to modulate the biology of platelets based upon a nucleic acid ligand that can interact with and modulate the activity of platelet glycoprotein GPVI to regulate platelet function. These nucleic acid ligands are also actively reversible using a modulator that inhibits the activity of the nucleic acid ligand to neutralize this pharmacologic effect and thereby restore GPVI function, including collagen binding, platelet adhesion, collagen-induced platelet activation, and collagen-induced platelet aggregation.  The invention further relates to compositions comprising the nucleic acid ligand, the ligand and a modulator, methods to generate the nucleic acid ligand and its modulator, as well as methods of using these agents and compositions in medical therapeutic and diagnostic procedures.
Patent CA-2766029-A1 (CA)
Inventor: SMITH JANET
IPC: G06Q20/40
Filed: 2012-01-27
Abstract: A computer system for fraud detection associated with a card-not-present payment card system is provided. The system includes a network host site and an interchange network including a processor communicatively coupled to a memory device for storing data and to the network host site wherein the processor is programmed to receive a card transaction authorization request message from a merchant, route the card transaction authorization request to the network host site to perform CNP fraud risk scoring, and based on the criteria of the card transaction authorization request, call at least one of a plurality of fraud scoring models defined for criteria of the transaction authorization request. The processor is further programmed to calculate the fraud risk score based on the current transaction authorization request data and an updated card account profile, and transmit the message to an issuer of the payment card for approval of the request.
Patent CA-2766685-A1 (CA)
Inventor: DONNAY MANUEL L
IPC: A61M37/00
Filed: 2011-03-24
Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided, as methods of inserting medical devices.
Patent CA-2772835-A1 (CA)
Title: Protective device, particularly for a lock of a door or leaf
Inventor: OLIANA PIER LUIGI
IPC: E05B17/00
Filed: 2012-03-29
Abstract: A protective device, particularly for a lock of a door or leaf, comprising a covering element which is associated slidingly with a plate that can be fixed to the door or leaf and can be positioned selectively so as to close an opening for access to the lock which is provided in the plate. Two pins are associated transversely with the plate and are adapted to block temporarily the sliding of the covering element with respect to the plate. The device has at least one cam, freely mounted rotatably within a cavity provided in the plate. At least one first recess and at least one second recess are provided in the lateral surface of the at least one cam, which have, in plan view, a mutually different shape and are adapted respectively to allow and prevent the sliding of the covering element.
Patent CA-2774570-A1 (CA)
Title: Pivoting shelters
Inventor: WAY MANSEN
IPC: E04H15/00
Filed: 2012-04-17
Abstract: A pivoting shelter comprises a support member, such as a support post. A pivot is affixed to the support member. The pivoting shelter has a shelter member attached to the pivot such that the shelter member is capable of rotating relative to the support member about a rotational axis. The pivot is attached to the shelter member so that the rotational axis is substantially perpendicular to a primary plane of the shelter member and at a position along the side of the shelter member other than the center of a side. For example, the rotational axis may be located substantially at a corner of the shelter member. In another embodiment according to the present invention, the pivot is attached to the shelter member such that the rotational axis is located on, or in front of, a line which is perpendicular to the direction of travel of a vehicle in the drive up lane and the line is tangential with a front edge of the shelter member.
Patent CA-2775008-A1 (CA)
Title: Separator for separating amalgam
Inventor: PREGENZER BRUNO
IPC: A61C17/00
Filed: 2010-04-23
Abstract: The present invention relates to a separator for separating amalgam from a dental effluent, having a housing with an opening for admitting the effluent and an opening for discharging the effluent and having a separating means arranged in the housing such that the effluent flows through the separating means. The separating means is designed to separate the amalgam from the dental effluent, wherein the separating means consists of a plurality of superimposed layers of a carrier material and lump-form material arranged between said layers.